首頁 > 市場調查報告書 > 醫療設備

中央實驗室市場規模、佔有率、成長分析（按服務、最終用戶和地區）- 產業預測（2025 年至 2032 年）

市場調查報告書

商品編碼

1796138

中央實驗室市場規模、佔有率、成長分析（按服務、最終用戶和地區）- 產業預測（2025 年至 2032 年）

Central Lab Market Size, Share, and Growth Analysis, By Services (Biomarker Services, Genetic Services), By End-User (Pharmaceutical Companies, Biotechnology Companies), By Region - Industry Forecast 2025-2032

出版日期: 2025年08月12日 | 出版商:

SkyQuest | 英文 195 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球中央實驗室市場價值將達到 30 億美元，到 2032 年將達到 52.4 億美元，預測期內（2025-2032 年）的複合年成長率為 6.4%。

全球中央實驗室市場正經歷顯著成長，這得益於對高效臨床試驗流程日益成長的需求、日益複雜的醫藥市場發展以及對經濟高效的集中診斷服務的需求。實驗室自動化的創新、醫藥研發投資的增加以及合約研究組織 (CRO) 和生物技術公司擴大使用綜合化驗服務，都助長了這一趨勢。人工智慧、機器學習和雲端基礎系統等技術正在增強實驗室業務，加速臨床試驗結果的產生。此外，個人化醫療和生物標記檢測的激增，也加劇了對集中實驗室模式的依賴，以確保準確性和及時性。雖然數位化整合和數據準確性的提升正在推動市場潛力的釋放，但高昂的初始投資和資料安全問題等挑戰可能會帶來暫時的限制，尤其是在新興市場。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 按部門分類的公司佔有率分析
- 收益同比對比（2022-2024 年）

主要企業簡介

ACM Global Laboratories
Eurofins Scientific
ICON plc
Labcorp
Thermo Fisher Scientific
Cerba Research
Medicover Integrated Clinical Services
Medspace
Bioscientia
Barc Lab
CIRION BioPharma Research

結論和建議

簡介目錄

Product Code: SQMIG35D2345

Global Central Lab Market size was valued at USD 3.0 billion in 2023 and is poised to grow from USD 3.19 billion in 2024 to USD 5.24 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The Global Central Lab market is experiencing significant growth driven by increasing demands for efficient clinical trial processes, the complexities of drug development, and a need for cost-effective centralized diagnostic services. Innovations in laboratory automation, rising investments in pharmaceutical research and development, and the heightened use of integrated lab services by CROs and biotech firms contribute to this trend. Technologies like AI, machine learning, and cloud-based systems are enhancing lab operations and expediting clinical study outcomes. Furthermore, the surge in personalized medicine and biomarker testing is fostering a reliance on centralized lab models for accuracy and timeliness. While digital integration and improved data accuracy bolster market potential, challenges such as high initial investments and data security issues may pose temporary constraints, especially in developing regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Central Lab market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Central Lab Market Segments Analysis

Global Central Lab Market is segmented by Services, End-User and region. Based on Services, the market is segmented into Biomarker Services, Genetic Services, Microbiology Services, Special Chemistry Services, Histology and Specimen Management & Storage. Based on End-User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Central Lab Market

The central lab market is experiencing significant growth driven by the increasing number of clinical trials, especially in areas such as oncology, rare diseases, and vaccines. Central labs offer consistent testing, standardized data management, and rapid reporting across various study locations, which are essential for enhancing trial efficiency and reliability. As multinational pharmaceutical companies expand their portfolios, there is a heightened demand for laboratories that can ensure regulatory compliance while also optimizing operational performance. This trend reflects the broader shift towards more complex and diverse research endeavors, further underscoring the importance of central labs in contemporary clinical development.

Restraints in the Global Central Lab Market

The Global Central Lab market faces significant constraints due to the substantial investment required for establishing and maintaining central lab facilities. This includes high expenditures for specialized equipment, advanced technology platforms, data management systems, and the recruitment of skilled personnel. These considerable capital and ongoing operational costs create barriers for smaller laboratories and emerging contract research organizations, ultimately restricting their potential for growth and market penetration. As a result, the financial burden associated with developing and continuing lab operations can hinder innovation and limit the overall expansion of the market.

Market Trends of the Global Central Lab Market

The Global Central Lab market is witnessing a notable trend driven by the increasing adoption of outsourcing among pharmaceutical and biotechnology firms. This shift allows these organizations to leverage enhanced scalability, extensive international trial coverage, and improved regulatory harmonization, which are critical for navigating the complexities of clinical trials. As companies seek to optimize resources and streamline operations, central lab services are becoming increasingly essential, offering specialized expertise and cutting-edge technology. This trend is anticipated to enhance operational efficiencies while also facilitating faster and more reliable data collection and analysis, ultimately contributing to the acceleration of drug development timelines and improved patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies
Customer Buying Behavior Analysis

Global Central Lab Market Size by Services & CAGR (2025-2032)

Market Overview
Biomarker Services
Genetic Services
Microbiology Services
Special Chemistry Services
Histology
Specimen Management & Storage

Global Central Lab Market Size by Instrumentation & CAGR (2025-2032)

Market Overview
Automated Analyzers
Microscopy
Spectrometry
Chromatography
Electrophoresis

Global Central Lab Market Size by Technology & CAGR (2025-2032)

Market Overview
Polymerase Chain Reaction (PCR)
Immunohistochemistry
Flow Cytometry
Mass Spectrometry
Next Generation Sequencing

Global Central Lab Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical Companies
Biotechnology Companies
Academics
Research Institutes

Global Central Lab Market Size & CAGR (2025-2032)

North America (Services, Instrumentation, Technology, End-User)
- US
- Canada
Europe (Services, Instrumentation, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Services, Instrumentation, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Services, Instrumentation, Technology, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Services, Instrumentation, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

ACM Global Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerba Research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medicover Integrated Clinical Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medspace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioscientia
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Barc Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CIRION BioPharma Research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments